Shareholders’ Deficit - Schedule of Stock Option Activity (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of Stock Option Activity [Abstract] | ||
| Number, Outstanding at beginning of period | 61,579 | 50,937 |
| Weighted Average Exercise Price, Outstanding at beginning of period | $ 6.94 | $ 15.57 |
| Number, Granted during the period | 75,000 | 48,055 |
| Weighted Average Exercise Price, Granted during the period | $ 2.2 | $ 5.84 |
| Number, Exercised during the period | ||
| Weighted Average Exercise Price, Exercised during the period | ||
| Number, Forfeited during the period | (788) | (37,413) |
| Weighted Average Exercise Price, Forfeited during the period | $ (17.33) | $ (17.48) |
| Number, Outstanding at ending period | 135,791 | 61,579 |
| Weighted Average Exercise Price, Outstanding at ending period | $ 4.26 | $ 6.94 |
| Number, Options exercisable at period-end | 102,791 | 48,074 |
| Weighted Average Exercise Price, Options exercisable at period-end | $ 4.6 | $ 6.94 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|